New perspectives in the diagnosis of hepatitis C

Seminars in Liver Disease

Volumn 19, Issue 1 SUPPL. 1, 1999, Pages 3-16

  Schiff, Eugene R ^a   De Medina, Maria ^a   Kahn, Rizwana S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic hepatitis C; Diagnosis; Enzyme linked immunosorbent assay; Recombinant immunoblot assay; Reverse transcriptase polymerase chain reaction

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY DETECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOBLOTTING; LIVER BIOPSY; LIVER HISTOLOGY; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0032953098     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362
2. Pawlotsky JM, Lonjon I, Hezode C, et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998;27:1700-1702
3. de Medina M, Schiff ER. Hepatitis C: diagnostic assays. Semin Liver Dis 1995;15:33-40
4. Lok AS, Gunaratnam NT. Diagnosis of hepatitis C. Hepatology 1997;26(suppl 1):48S-56S
5. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997:26(suppl 1):43S-47S
6. Leon R, de Medina M, Schiff ER. Diagnostic tools in the evaluation of patients with viral hepatitis undergoing liver transplantation. Liver Transpl Surg 1998;4:94-103
7. Smith J, Osikowicz G. Abbott AxSYM random and continuous access immunoassay system for improved workflow in the clinical laboratory. Clin Chem 1993;39:2063-2069
8. Khalil OS, Zurek TF, Tryba J, et al. Abbott prism: a multichannel heterogeneous chemiluminescence immunoassay analyzer. Clin Chem 1991;37:1540-1547
9. Damen M, Zaaijer HL, Cuypers HT, et al. Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus. Transfusion 1995;35:745-749
10. Frangeul L, Cresta P, Perrin M, et al. Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon. J Hepatol 1998;28:538-543
11. Lu RH, Hwang SJ, Chan CY, Chang FY, Lee SD. Quantitative measurement of serum HCV-RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay. J Clin Lab Anal 1998;12:121-125
12. Zaaijer HL, Cuypers HT, Reesink HW, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-724
13. Kamisango K, Kamogawa C, Sumi M, et al. Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay. J Clin Microbiol 1999; 37:310-314
14. Jacob S, Baudy D, Jones E, et al. Comparison of quantitative HCV-RNA assays in chronic hepatitis C. Am J Clin Pathol 1997;107:362-367
15. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339: 1493-1499
16. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-1492
17. Poynard T, Marcellin P, Lee S, et al. Randomised trial of interferon alfa-2b and ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352: 1426-1432
18. Urdea MS, Horn T, Fultz TJ, et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Symp Ser 1991;24:197-200
19. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol 1997;35:187-192
20. Conrad A. Los Angeles, Calif: National Genetics Institute: 1998
21. Roth WK, Lee JH, Ruster B, Zeuzem S. Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method. Z Gastroenterol 1998;36:5-11
22. Lunel F, Cresta P, Vitour D, et al. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays. Hepatology 1999;29:528-535
23. Bresters D, Cuypers HT, Reesink HW, et al. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. J Med Virol 1994;43:262-268
24. Negro F, Krawczynski K, Quadri R. et al. Detection of genomic-and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction. Hepatology 1999; 29:536-542
25. Pawlotsky JM, Prescott L, Simmonds P, et al. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 1997;26:1-4
26. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41-63
27. Lee JH, Stripf T, Roth WK, Zeuzem S. Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism. J Med Virol 1997;53:245-251
28. Maertens G, Stuyver L. Genotypes and genetic variation of hepatitis C virus. In: Harrison TJ, Zuckerman AJ. The Molecular Medicine of Viral Hepatitis. New York, NY: John Wiley & Sons; 1997:183-233
29. Senturk H, Uzunalimoglu O, Batur Y, et al. Long-term efficacy of interferon-a and ursodeoxycholic acid in treatment of chronic type C hepatitis. Dig Dis Sci 1997;42:1438-1444
30. Polyak SJ, McArdle S, Liu SL, et al. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 1998;72:4288-4296
31. Laskus T, Radkowski M, Wang LF, et al. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology 1998;248:164-171
32. Zeuzem S, Franke A, Lee JH, et al. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 1996;24:1003-1009
33. Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996;34:2259-2266
34. Stuyver L, Rossau R, Maertens G. Line probe assays for the deduction of hepatitis B and C virus genotypes. Antiviral Ther 1996;1(suppl 3):53-57
35. Lau JY, Davis GL, Prescott LE, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 1996;124:868-876
36. Lopez-Labrador FX, Ampurdanes S, Forns X, et al. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997;27:959-965
37. Pawlotsky JM, Prescott L, Simmonds P, et al. Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Microbiol 1997;35:1734-1739
38. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-1340
39. Negro F, Giostra E, Krawczynski K, et al. Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quanti-tative RT-PCR: preliminary application to the liver transplantation model. J Hepatol 1998;29:1-11
40. Shieh YS, Shim KS, Lampertico P, et al. Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction. Lab Invest 1991;65:408-411
41. Haydon GH, Jarvis LM, Blair CS, et al. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection [see comments]. Gut 1998;42:570-575
42. Larghi A, Tagger A, Crosignani A, et al. Clinical significance of hepatic HCV-RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy. J Med Virol 1998;55:7-11
43. Walker FM, Dazza MC, Dauge MC, et al. Detection and localization by in situ molecular biology techniques and immunohistochemistry of hepatitis C virus in livers of chronically infected patients. J Histochem Cytochem 1998;46:653-660
44. Brody RI, Eng S, Melamed J, et al. Immunohistochemical detection of hepatitis C antigen by monoclonal antibody TORDJI-22 compared with PCR viral detection. Am J Clin Pathol 1998; 110:32-37
45. Vargas V, Krawczynski K, Castells L, et al. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen. Liver Transpl Surg 1998; 4:320-327
46. Wong VS, Hughes V, Trull A, et al. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepatitis 1998;5:187-192
47. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-1616
48. Jeffers LJ, Coelho-Little ME, Cheinquer H, et al. Procollagen-III peptide and chronic viral C hepatitis. Am J Gastroenterol 1995;90:1437-1440